Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis

Objective. More and more evidences demonstrate that androgen receptor (AR), epidermal growth factor receptor (EGFR), and breast cancer susceptibility gene 1 (BRCA1) have unique clinical implications for targeted therapy or prognosis in triple-negative breast cancer (TNBC). Therefore, we conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Fang, Cheng, Xu, Xianqun, Li, Anling, Cai, Qing, Long, Xinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324735/
https://www.ncbi.nlm.nih.gov/pubmed/25695063
http://dx.doi.org/10.1155/2015/357485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324735/
https://www.ncbi.nlm.nih.gov/pubmed/25695063
http://dx.doi.org/10.1155/2015/357485

Ejemplares similares